Search company, investor...

Founded Year


About Nano Therapeutics

Nano Therapeutics specializes in the development and manufacturing of cardiovascular and vascular medical devices within the healthcare sector. The company offers a range of products including coronary stents, drug-eluting balloons, and support devices designed to address cardiac and vascular conditions. Nano Therapeutics primarily serves the healthcare industry, providing innovative solutions to healthcare professionals and patients. It was founded in 2011 and is based in Surat, India.

Headquarters Location

Plot No. D-54/2, Hojiwala Industrial Estate Road No. 23, Near Gate No. 3,

Surat, 394 230,




Latest Nano Therapeutics News

Peripheral Vascular Devices Market Set to Reach US$ 8.6 Billion by 2031 - In-Depth Industry Analysis and Trends Overview

Feb 14, 2024

The global peripheral vascular devices market is on an upward trajectory, projected to propel it to a valuation of US$ 8.6 billion by the end of 2031. In 2024, the market is set to generate revenues of US$ 4.9 billion, with peripheral vascular stents accounting for a substantial portion. Driving Factors and Market Expansion A pivotal element bolstering market development is the increased volume of surgeries, paired with more accessible insurance reimbursements. Progress in outpatient methodologies for peripheral vascular interventions, especially noticeable in affluent economies, is a result of sweeping reforms in reimbursement strategies and targeted governmental support. Challenges in the Peripheral Vascular Devices Market The path to market supremacy is not without its hurdles. A pressing concern is the potential for product recalls, as these medical devices are subject to stringent regulatory scrutiny, especially when introducing cutting-edge technology. Adverse health events associated with these tools are a considerable obstacle, as the market’s stability is occasionally shaken by recalls set into motion by authorities such as the FDA. Regional Market Highlights The United States maintains a formidable presence, making up the lion's share of North America's sector at 94.5%. Germany takes the limelight in Europe with its robust R&D initiatives and swift technology assimilation. Furthermore, China's prominence in East Asia owes much to the country's demographic structure and disease prevalence, fostering a ripe environment for market penetration. Competition and Key Market Players The landscape is highly competitive, with industry giants pushing the envelope with innovation and strategic alliances to consolidate their market positions. Abbott Laboratories. Boston Scientific Corporation, Medtronic and others, are among the key companies profiled in the study, with their market strategies and portfolios carefully examined. Research Segmentation Peripheral Vascular Stents and Drug Eluting Balloons Target Artery Instability and Peripheral Arterial Disease End-users: Hospitals, Ambulatory Surgical Centers, and Cardiac Cath Labs Key Regions: North America, Europe, Asia-Pacific, and more This segmentation captures a comprehensive view of the market, enabling tailored strategic decision-making for industry participants. Companies Profiled Getinge AB iVascular S.L.U Nano Therapeutics Pvt Ltd

Nano Therapeutics Frequently Asked Questions (FAQ)

  • When was Nano Therapeutics founded?

    Nano Therapeutics was founded in 2011.

  • Where is Nano Therapeutics's headquarters?

    Nano Therapeutics's headquarters is located at Plot No. D-54/2, Hojiwala Industrial Estate, Surat.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.